These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27410520)

  • 21. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.
    Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J
    Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine metabolomics reveals biomarkers and the underlying pathogenesis of diabetic kidney disease.
    Luo M; Zhang Z; Lu Y; Feng W; Wu H; Fan L; Guan B; Dai Y; Tang D; Dong X; Yun C; Hocher B; Liu H; Li Q; Yin L
    Int Urol Nephrol; 2023 Apr; 55(4):1001-1013. PubMed ID: 36255506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR-based metabolomics associated with chronic kidney disease in humans and animals: a one health perspective.
    Hunter E; Percival B; Ahmad Z; Chang MW; Hunt JA; Tasker S; De Risio L; Wilson PB
    Mol Cell Biochem; 2021 Nov; 476(11):4133-4137. PubMed ID: 34312783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.
    Hallan S; Afkarian M; Zelnick LR; Kestenbaum B; Sharma S; Saito R; Darshi M; Barding G; Raftery D; Ju W; Kretzler M; Sharma K; de Boer IH
    EBioMedicine; 2017 Dec; 26():68-77. PubMed ID: 29128444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease.
    Kordalewska M; Macioszek S; Wawrzyniak R; Sikorska-Wiśniewska M; Śledziński T; Chmielewski M; Mika A; Markuszewski MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():49-57. PubMed ID: 30999273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabonomic analysis of potential biomarkers and drug targets involved in diabetic nephropathy mice.
    Wei T; Zhao L; Jia J; Xia H; Du Y; Lin Q; Lin X; Ye X; Yan Z; Gao H
    Sci Rep; 2015 Jul; 5():11998. PubMed ID: 26149603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease.
    Cañadas-Garre M; Anderson K; McGoldrick J; Maxwell AP; McKnight AJ
    J Proteomics; 2019 Feb; 193():93-122. PubMed ID: 30292816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators.
    Cordero-Pérez P; Sánchez-Martínez C; García-Hernández PA; Saucedo AL
    Nefrologia (Engl Ed); 2020; 40(6):585-596. PubMed ID: 33036786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers in diabetic kidney disease: good use and pitfalls.
    Titan S
    Arch Endocrinol Metab; 2016 Apr; 60(2):92-4. PubMed ID: 27191045
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolomics and renal disease.
    Rhee EP
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):371-9. PubMed ID: 26050125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics.
    Ibarra-González I; Cruz-Bautista I; Bello-Chavolla OY; Vela-Amieva M; Pallares-Méndez R; Ruiz de Santiago Y Nevarez D; Salas-Tapia MF; Rosas-Flota X; González-Acevedo M; Palacios-Peñaloza A; Morales-Esponda M; Aguilar-Salinas CA; Del Bosque-Plata L
    Acta Diabetol; 2018 Nov; 55(11):1151-1161. PubMed ID: 30173364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GC-MS-based Metabolomic Profiling of Thymoquinone in Streptozotocin-induced Diabetic Nephropathy in Rats.
    Raish M; Ahmad A; Jan BL; Alkharfy KM; Mohsin K; Ahamad SR; Ansari MA
    Nat Prod Commun; 2017 Apr; 12(4):553-558. PubMed ID: 30520595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics.
    Tavares G; Venturini G; Padilha K; Zatz R; Pereira AC; Thadhani RI; Rhee EP; Titan SMO
    Metabolomics; 2018 Feb; 14(4):39. PubMed ID: 30830377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum integrative omics reveals the landscape of human diabetic kidney disease.
    Liu S; Gui Y; Wang MS; Zhang L; Xu T; Pan Y; Zhang K; Yu Y; Xiao L; Qiao Y; Bonin C; Hargis G; Huan T; Yu Y; Tao J; Zhang R; Kreutzer DL; Zhou Y; Tian XJ; Wang Y; Fu H; An X; Liu S; Zhou D
    Mol Metab; 2021 Dec; 54():101367. PubMed ID: 34737094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-FABP: A novel biomarker of kidney disease.
    Xu Y; Xie Y; Shao X; Ni Z; Mou S
    Clin Chim Acta; 2015 May; 445():85-90. PubMed ID: 25797895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.
    Jin Q; Lau ESH; Luk AO; Tam CHT; Ozaki R; Lim CKP; Wu H; Chow EYK; Kong APS; Lee HM; Fan B; Ng ACW; Jiang G; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Cheung EYN; Kam G; Lau IT; Li JK; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Yu W; Tsui SKW; Tomlinson B; Huang Y; Lan HY; Szeto CC; So WY; Jenkins AJ; Fung E; Muilwijk M; Blom MT; 't Hart LM; Chan JCN; Ma RCW;
    Diabetologia; 2024 May; 67(5):837-849. PubMed ID: 38413437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic Nephropathy.
    Siwy J; Ahonen L; Magalhães P; Frantzi M; Rossing P
    Methods Mol Biol; 2020; 2067():287-306. PubMed ID: 31701458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Warburg Effect in Diabetic Kidney Disease.
    Zhang G; Darshi M; Sharma K
    Semin Nephrol; 2018 Mar; 38(2):111-120. PubMed ID: 29602394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans.
    Zhang ZH; Chen H; Vaziri ND; Mao JR; Zhang L; Bai X; Zhao YY
    J Proteome Res; 2016 Oct; 15(10):3802-3812. PubMed ID: 27636000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.